Siponimod cuts risk of disability progression in multiple sclerosis
(HealthDay)—For patients with secondary progressive multiple sclerosis, the selective sphingosine 1-phosphate (S1P) receptor1,5 modulator, siponimod, is associated with reduced relative risk of confirmed disability progression, ...
Mar 23, 2018
0
11